The oestrogen receptor regulates NFκB and AP-1 activity in a cell- specific manner

Journal of Steroid Biochemistry and Molecular Biology

Volumn 67, Issue 2, 1998, Pages 79-88

  Cerillo, Georgia ^a   Rees, Amanda ^a   Manchanda, Nina ^a   Reilly, Christopher ^a   Brogan, Iain ^b   White, Anne ^b   Needham, Maurice ^a  

^a Musculo skeletal Metab Res D   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR;

ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; REPORTER GENE; TRANSCRIPTION REGULATION;

BETA-GALACTOSIDASE; DEXAMETHASONE; ESTROGENS; GENE EXPRESSION REGULATION; GENES, REPORTER; HELA CELLS; HUMANS; NF-KAPPA B; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 0032192404     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00078-8     Document Type: Article

References (53)

1. Tsai M. J., O'Malley B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann. Rev. Biochem. 63:1994;451-486.
2. Green S., Walter P., Kumar V., Krust A., Bornert J. M., Argos P., Chambon P. Human oestrogen receptor cDNA and homology to v-erb-A. Nature. 320:1986;134-139.
3. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
4. Beato M. Gene regulation by steroid hormones. Cell. 56:1989;335-344.
5. Kumar V., Green S., Stack G., Berry M., Jin J. R., Chambon P. Functional domains of the human estrogen receptor. Cell. 51:1987;941-951.
6. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., Chambon P. The human estrogen receptor has two independent non-acidic transciptional activation functions. Cell. 59:1989;477-487.
7. Barnes P. J., Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. TiPS. 14:1993;436-441.
8. Beekman J. M., Allan G. F., Tsai M., O'Malley B. W. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Molec. Endocr. 7:1993;1266-1274.
9. Kumar V., Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell. 55:1988;145-156.
10. Sakai D. D., Helms S., Carlstedt-Duke J., Gustafsson J.-A., Rottman F. M., Yamamoto K. R. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Development. 2:1988;1144-1154.
11. Stein B., Yang M. X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ Molec. Cell Biol. 15:1995;4971-4979.
12. Kurebayashi S., Miyashita Y., Hirose T., Kasayama S., Akira S., Kishimoto T. Characterisation of mechanisms of interleukin-6 gene repression by estrogen receptor. J. Steroid Biochem. Molec. Biol. 60:1997;11-17.
13. Ray A., Prefontaine K. E. Physical association and funtional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 91:1994;752-756.
14. Scheinman R. I., Gualberto A., Jewell C. M., Cidlowski J. A., Baldwin A. S. Jr. Characterisation of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Molec. Cell Biol. 15:1995;943-953.
15. Schule R., Rangarajian P., Kliewer S., Ransone L. J., Bolado J., Yang N., Verma I. M., Evans R. M. Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell. 62:1990;1217-1227.
16. Yang-Yen H.-F., Chambard J.-C., Sun Y.-L., Smeal T., Schmidt T. J., Drouin J., Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptors: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 62:1990;1205-1215.
17. Jonat C., Rahmsdorf H. J., Park K.-K., Cato A. C. B., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 62:1990;1189-1204.
18. Kalkhoven E., Wissink S., van der Saag P. T., van der Burg B. Negative interaction between the RelA (p65) subunit of NF-κB and the progesterone receptor. J. Biol. Chem. 271:1996;6217-6224.
19. Wissink S., van Heerde E. C., Schmitz M. L., Kalkhoven E., van der Burg B., Baeuerle P. A., van der Saag P. T. Distinct domains of the RelA NF-κB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J. Biol. Chem. 272:1997;22278-22284.
20. DeBosscher K., Schmitz M. L., Vanden Berghe W., Plaisance S., Fiers W., Haegman G. Glococrticoid-mediated repression of nuclear factor-κB-dependent transactivation involves direct interference with transactivation. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13504-13509.
21. Kamei Y., Xu L., Thorsten H., Torchia J., Kurokawa R., Gloss B., Lin S.-C., Heyman R. A., Rose D. W., Glass C. K., Rosenfeld M. G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
22. Cavailles V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P. J., Parker M. G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:1995;3741-3751.
23. Halachmi S., Marden E., Martin G., MacKay I., Abbondanza C., Brown M. Estrogen receptor-associated proteins: possible mediators of hormone induced transcription. Science. 264:1994;1455-1458.
24. Hanstein B., Ecker R., DiRenzo J., Halachmi S., Liu H., Searcy B., Kurokawa R., Brown M. p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11540-11545.
25. Horwitz K. B., Jackson T. A., Bain D. L., Richer J. K., Takimoto G. S., Tung L. Nuclear receptor coactivators and corepressors. Molec. Endocr. 10:1996;1167-1177.
26. Jackson T. A., Richer J. K., Bain D. L., Takimoto G. S., Tung L., Horwitz K. B. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Molec. Endocr. 11:1997;693-705.
27. Onate S. A., Tsai S. Y., Tsai M.-J., O'Malley B. W. Sequence and characterisation of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
28. Shibata, H., Spencer, T. E., Onate, S. A., Jenster, G., Tsai, S. Y., Tsai, M.-J. and O'Malley, B. W., Role of coactivators and corepressors in the mechanism of steroid/thyroid receptor action. Recent Progress in Hormone Research, 52 1997 (in press).
29. Smith C. L., Nawaz Z., O'Malley B. W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Molec. Endocr. 11:1997;657-666.
30. Yao T.-P., Ku G., Zhou N., Scully R., Livingston D. M. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl. Acad. Sci. U.S.A. 93:1996;10626-10631.
31. Cavailles V., Dauvois S., Danielian P. S., Parker M. G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natn. Acad. Sci. U.S.A. 91:1994;10009-10013.
32. Webb P., Lopez G. N., Uht R. M., Kushner P. J. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin of the cell-specific estrogen-like effects of anti-estrogens. Molec. Endocr. 9:1995;443-456.
33. Uht R. M., Anderson C. M., Webb P., Kushner P. J. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology. 138:1997;2900-2908.
34. Ray A., Perfontaine K. E., Ray P. Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem. 269:1994;12940-12946.
35. Gaub M. P., Bellard M., Scheuer L., Chambon P., Sasson-Corsi P. Activation of the ovalbumin gene by the estrogen receptor involves the fos/jun complex. Cell. 63:1990;1267-1276.
36. Pottratz S. T., Bellida T., Mocharla H., Crabb D., Manolagas S. C. 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor dependent mechanism. J. Clin. Invest. 93:1994;944-950.
37. Jilka R. L., Hangoc G., Girasole G., Passeri G., Williams D. C., Abrams J. S., Boyce B., Broxmeyer H., Manolagas S. C. Increased osteoclast develpoment after estrogen loss: mediation by interleukin-6. Science. 257:1992;88-91.
38. Girasole G., Jilka R. L., Passeri G., Boswell S., Boder G., Williams D. C., Manolagas S. C. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in-vitro : a potential mechanism for the antiosteoporotic effects of estrogens. J. Clin. Invest. 89:1992;883-891.
39. Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1990;1897-1906.
40. Ray A., Sassone-Corsi P., Seghal P. B. A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Molec. Cell Biol. 9:1989;5537-5547.
41. Tora L., Mullik A., Ponglikitmongkol M., Park I., Chambon P. The cloned human estrogen receptor contains a mutation that alters its hormone binding properties. EMBO J. 8:1989;1981-1986.
42. Wigler M., Sweet R., Sim G. K., Wold B., Pellicer A., Lacy E., Maniatis T., Silverstein S., Axel R. Transformation of mammalian cells with genes from procaryotes and eukaryotes. Cell. 16:1979;777-785.
43. Dixon G., Scanlon D., Cooper S., Broad P. A reporter gene assay for fungal sterol biosynthesis inhibitors. J. Steroid Biochem. Molec. Biol. 62:1997;165-171.
44. Galien R., Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κB site. Nucl. Acids Res. 25:1997;2424-2429.
45. Caulin-Glaser T., Watson C. A., Pardi R., Bender J. R. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expresion. J. Clin. Invest. 98:1996;36-42.
46. Frazier-Jessen M. R., Kovacs E. J. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J. Immunol. 154:1995;1838-1845.
47. Heery D. M., Kalkhoven E., Hoare S., Parker M. G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736.
48. Glass C. K., Rose D. W., Rosenfeld M. G. Nuclear receptor coactivators. Current Opinion Cell Biol. 9:1997;222-232.
49. Kuiper G. G. J. M., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.-A. Cloning of a novel estrogen-receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5925-5930.
50. Kuiper G. G. J. M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-A. Comparison of the ligand-binding specificity and transcript tissue distribution of estrogen-receptor-alpha and estrogen-receptor-beta. Endocrinology. 138:1997;863-870.
51. Mosselman S., Polman J., Dijkema R. ER-beta: identification and characterisation of a novel human estrogen receptor. FEBS Letts. 392:1996;49-53.
52. Kuiper G. G. J. M., Gustafsson J.-A. The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Letts. 410:1997;87-90.
53. Paech K., Webb P., Kuiper G. G. J. M., Nilsson S., Gustafsson J.-A., Kushner P. J., Scanlan T. S. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science. 277:1997;1508-1510.